C/M Capital Partners, Lp - May 20, 2025 SCHEDULE 13G Report for Biodexa Pharmaceuticals Plc Ordinary Shares, nominal value 0.00005 GBP per share (BDRX)

Filing Manager: C/M CAPITAL PARTNERS, LP
Reporting Manager: Jonathan Juchno
Security: Biodexa Pharmaceuticals Plc Ordinary Shares, nominal value 0.00005 GBP per share
Symbol: BDRX
Shares outstanding: 25.8B shares
Disclosed Ownership: 1.75B shares
Ownership: 6.8%
Form type: SCHEDULE 13G
Date filed: 5/28/2025, 05:59 PM
Date of event: May 20, 2025
Previous filing: Feb 18, 2025
SEC: View on sec.gov

Reporting Managers (8)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Cavalry Fund I LP	5.7%	1.46B	1.46B	/s/ Thomas Walsh	By: Cavalry Fund I GP LLC, General Partner, By: Thomas Walsh, Manager
C/M Capital Partners, LP	5.7%	1.46B	1.46B	/s/ Thomas Walsh	Thomas Walsh, Partner
Cavalry Investment Fund LP	0.3%	74.8M	74.8M	/s/ Thomas Walsh	By: Cavalry Fund GP, LLC, General Partner, By: Thomas Walsh, Managing Member
Cavalry Fund I Management LLC	0.3%	74.8M	74.8M	/s/ Thomas Walsh	Thomas Walsh, Manager
Mercer Street Global Opportunity Fund, LLC	1.1%	292M	292M	/s/ Jonathan Juchno	By: NFSO, LLC, its General Partner, By: Jonathan Juchno, Authorized Representative
Mercer Street Capital Partners, LLC	1.1%	292M	292M	/s/ Jonathan Juchno	Jonathan Juchno, Authorized Representative
Thomas Walsh	6%	1.54B	1.54B	/s/ Thomas Walsh	Thomas Walsh, Individually
Jonathan Juchno	6.8%	1.75B	1.75B	/s/ Jonathan Juchno	Jonathan Juchno, Individually